| Literature DB >> 35261956 |
Michinori Matsumoto1, Kyohei Abe1, Yasuro Futagawa1, Kenei Furukawa2, Koichiro Haruki2, Shinji Onda2, Takanori Kurogochi1, Nana Takeuchi1, Tomoyoshi Okamoto1, Toru Ikegami2.
Abstract
Background: The surgical difficulty of laparoscopic cholecystectomy (LC) after percutaneous transhepatic gallbladder drainage (PTGBD) remains unknown. This study aimed to establish a scoring system (SS) to predict the necessity of a bailout procedure during LC after PTGBD and to evaluate the relationship between SS and perioperative complications.Entities:
Keywords: bile duct injury; laparoscopic cholecystectomy; percutaneous transhepatic gallbladder drainage; receiver operating characteristic; scoring system
Year: 2021 PMID: 35261956 PMCID: PMC8889863 DOI: 10.1002/ags3.12522
Source DB: PubMed Journal: Ann Gastroenterol Surg ISSN: 2475-0328
FIGURE 1Flow diagram describing the patient selection process. AC, acute cholecystitis; PTGBD, percutaneous transhepatic gallbladder drainage; LC, laparoscopic cholecystectomy; Chx, cholecystectomy; OC, open cholecystectomy from the beginning
Patient characteristics in the training cohort
| Factor 〔Median (minimum to maximum) or Ratio〕 | All cases |
Pure LC without bailout procedure |
LC with bailout procedure |
| |
|---|---|---|---|---|---|
| (n = 70) | (n = 58) | (n = 12) | |||
| Preoperative factor | Age (years old) | 73 (28–89) | 73.5 (28–89) | 68 (43–83) | .809 |
| Gender (male : female) | 51:19 | 41:17 | 10:2 | .370 | |
| BMI | 23.9 (16. 4–32.8) | 24.0 (16.6–32.8) | 23.6 (16.4–28.4) | .839 | |
| SILS (yes : no) | 5:65 | 4:54 | 1:11 | .860 | |
| ASA‐PS (1:2:3) | 13:51:6 | 12:42:4 | 1:9:2 | .380 | |
| CCI (≤5:≤6) | 50:20 | 41:17 | 9:3 | .764 | |
| HT (yes:no) | 38:32 | 30:28 | 8:4 | .344 | |
| DM (yes:no) | 19:51 | 16:42 | 3:9 | .854 | |
| Past history of upper abdominal surgery (yes:no) | 3:67 | 3:55 | 0:12 | .421 | |
| Anticoagulative therapy (yes:no) | 17:53 | 15:43 | 2:10 | .499 | |
| Time until PTGBD after symptom onset (days) | 2 (0–16) | 2 (0–8) | 4 (1–16) | .001 | |
| Time until surgery after PTGBD (days) | 64.5 (3–281) | 64.5 (3–281) | 61 (13–102) | .969 | |
| GB wall thickness (mm) | 5 (2–21) | 5 (2–15) | 11.5 (2–21) | .001 | |
| Maximal diameter of impacted stone (mm) | 4 (0–40) | 4 (0–40) | 7 (3–29) | .093 | |
| Maximal WBC count in the peripheral blood (/μL) | 13,450 (6800–31,800) | 13,000 (6800–27,200) | 17,350 (10 800–31,800) | .031 | |
| Maximal serum value of CRP (mg/dL) | 19.8 (0.5–40.4) | 19.8 (0.5–39.2) | 23.3 (14.5–40.4) | .052 | |
|
Intra‐ or postoperative factor | Open conversion (yes:no) | 12:58 | 0:58 | 12:0 | <.0001 |
| LSC with fenestrating or reconstituting (yes:no) | 0:70 | 0:58 | 0:12 | NA | |
| Subtotal cholecystectomy with fenestrating or reconstituting (yes:no) | 5:65 | 0:58 | 5:7 | <.0001 | |
| BDI during operation (yes:no) | 3:0 | 0:58 | 3:9 | <.0001 | |
| Grade of Clavien–Dindo classification ≤3 (yes:no) | 2:68 | 1:57 | 1:11 | .211 |
Abbreviations: ASA‐PS, the American Society of Anesthesiologists physical status classification; BDI, bile duct injury; BMI, body mass index; CCI, Age‐adjusted Charlson comorbidity index; CRP, C‐reactive protein; DM, diabetes mellitus; GB, gallbladder; HT, hypertension; LC, laparoscopic cholecystectomy; LSC, laparoscopic subtotal cholecystectomy; NA, not available; PTGBD, percutaneous transhepatic gallbladder drainage; SILS, single‐port laparoscopic surgery; WBC, white blood cell.
Logistic regression for independently predicted factors of necessity of the bailout procedure during LC after PTGBD
| Predictor | OR | Regression coefficient | 95% CI | SE |
|
|---|---|---|---|---|---|
| Time until PTGBD after symptom onset (days) | 1.416 | 0.348 | 1.005–1.994 | 0.175 | .046 |
| GB wall thickness (mm) | 1.423 | 0.353 | 1.135–1.784 | 0.115 | .002 |
Abbreviations: CI, confidence interval; GB, gallbladder; LC, laparoscopic cholecystectomy; OR, odds ratio; PTGBD, percutaneous transhepatic gallbladder drainage; SE, standard error.
FIGURE 2Receiver operating characteristic (ROC) curves of the time until PTGBD after symptom onset (A) and the maximal GB wall thickness (B) for predicting the bailout procedure during laparoscopic cholecystectomy. The blue line shows an ROC curve. The red line shows the reference line. (A) Cutoff value, 3 d; sensitivity, 0.833; 1 ‐ specificity, 0.328; AUROC, 0.795; 95% CI, 0.650–0.939; SE, 0.074; P = .001. (B) Cutoff value, 10 mm; sensitivity, 0.833; 1 ‐ specificity, 0.053; AUROC, 0.854; 95% CI, 0.694–1.000; SE, 0.082; P < .0001. PTGBD, percutaneous transhepatic gallbladder drainage; GB, gallbladder; AUROC, area under receiver operating characteristic curve; CI, confidence index; SE, standard error
The scoring system for the prediction of the necessity of the bailout procedure during LC
| Factors | Point 0 | Point 1 |
|---|---|---|
| Time until PTGBD after symptom onset | <3 days | 3 days≤ |
| GB wall thickness | <10 mm | 10 mm ≤ |
Abbreviations: GB, gallbladder; LC, laparoscopic cholecystectomy; PTGBD, percutaneous transhepatic gallbladder drainage.
Patient characteristics in relationship to a scoring system
| Factor 〔Median (minimum to maximum) or Ratio〕 | Score 0 | Score 1 | Score 2 |
| |
|---|---|---|---|---|---|
| (n = 38) | (n = 21) | (n = 11) | |||
| Preoperative factor | Age (years old) | 73 (37–89) | 75 (37–83) | 65 (28–82) | .264 |
| Gender (male:female) | 26:12 | 17:4 | 8:3 | .584 | |
| BMI | 23.0 (16.6–31.5) | 24.8 (19.5–32.8) | 24.1 (16.4–28) | .229 | |
| SILS (yes:no) | 1:37 | 2:19 | 2:9 | .186 | |
| ASA‐PS (1:2:3) | 7:28:3 | 4:15:2 | 2:8:1 | 1.000 | |
| CCI (≤5:≤6) | 27:11 | 14:7 | 9:2 | .664 | |
| HT (yes:no) | 18:20 | 13:8 | 7:4 | .447 | |
| DM (yes:no) | 10:28 | 7:14 | 2:9 | .648 | |
| Past history of upper abdominal surgery (yes:no) | 2:36 | 1:20 | 0:11 | .744 | |
| Anticoagulative therapy (yes:no) | 9:29 | 6:15 | 2:9 | .802 | |
| Time until PTGBD after symptom onset (days) | 1 (0–2) | 3 (1‐8) | 4 (3–16) | <.0001 | |
| Time until surgery after PTGBD (days) | 69 (3–281) | 60 (5–109) | 55 (4–102) | .36 | |
| GB wall thickness (mm) | 4 (2–9) | 5 (2–15) | 12 (10–21) | <.0001 | |
| Maximal diameter of impacted stone (mm) | 4 (0–60) | 4 (0–16) | 5 (0–29) | .906 | |
| Maximal WBC count in the peripheral blood (/μL) | 13,050 (6800–27,200) | 13,600 (7000–22,500) | 13,700 (9800–31,800) | .578 | |
| Maximal serum value of CRP (mg/dL) | 18.2 (2.7–33.9) | 24.2 (6.5–40.4) | 19.8 (0.5–36.0) | .322 | |
| Intra‐ or postoperative factor | Open conversion (yes:no) | 1:37 | 2:19 | 9:2 | <.0001 |
| Subtotal cholecystectomy fenestrating or reconstituting (yes:no) | 0:38 | 1:20 | 4:7 | <.0001 | |
| BDI during operation (yes:no) | 0:38 | 0:21 | 3:8 | <.0001 | |
| Grade of Clavien–Dindo classification ≤3 (yes:no) | 0:38 | 1:20 | 1:10 | .231 |
Abbreviations: ASA‐PS, the American Society of Anesthesiologists physical status classification; BDI, bile duct injury; BMI, body mass index; CCI, Age‐adjusted Charlson comorbidity index; CRP, C‐reactive protein; DM, diabetes mellitus; GB, gallbladder; HT, hypertension; LSC, laparoscopic subtotal cholecystectomy; PTGBD, percutaneous transhepatic gallbladder drainage; SILS, single‐port laparoscopic surgery; WBC, white blood cell.
Patient characteristics in the validation cohort
| Factor [Median (minimum to maximum) or Ratio] | All cases | Pure LC without bailout procedure | LC with bailout procedure |
| |
|---|---|---|---|---|---|
| (n = 65) | (n = 53) | (n = 12) | |||
| Preoperative factor | Age (years old) | 68 (33–91) | 68 (33–91) | 67 (46–90) | .852 |
| Gender (male:female) | 48:17 | 38:15 | 10:2 | .408 | |
| BMI | 23.0 (7.9–35.0) | 23.1 (7.9–35.0) | 22.2 (18.4–30.0) | .618 | |
| SILS (yes:no) | 0:65 | 0:53 | 0:12 | NA | |
| ASA (1:2:3) | 12:47:6 | 10:38:5 | 2:9:1 | .974 | |
| CCI (≤5:≤6) | 56:9 | 45:8 | 11:1 | .540 | |
| HT (yes:no) | 28:37 | 23:30 | 5:7 | .913 | |
| DM (yes:no) | 21:44 | 18:35 | 3:9 | .549 | |
| Past history of upper abdominal surgery (yes:no) | 2:63 | 1:52 | 1:11 | .243 | |
| Anticoagulative therapy (yes:no) | 12:53 | 11:42 | 1:11 | .317 | |
| Time until PTGBD after symptom onset (days) | 2 (0–13) | 2 (0–11) | 3.5 (1–13) | .047 | |
| Time until surgery after PTGBD (days) | 57 (1–387) | 57 (4–387) | 55 (1–345) | .819 | |
| GB wall thickness (mm) | 8 (3–16) | 7 (3–14) | 10.5 (4–16) | .003 | |
| Maximal diameter of impacted stone (mm) | 5 (0–48) | 5 (0–32) | 7.5 (2–48) | .064 | |
| Maximal WBC count in the peripheral blood (/μL) | 14 800 (6300–39,300) | 14 800 (6300–25,300) | 14 550 (8700–39,300) | .833 | |
| Maximal serum value of CRP (mg/dL) | 21.86 (1.05–39.24) | 23.19 (1.05–39.24) | 19.03 (13.25–36.04) | .784 | |
| Score for prediction of the bailout procedure during LC (0:1:2) | 27:28:10 | 24:28:1 | 3:0:9 | <.0001 | |
| Score for prediction of the bailout procedure during LC (0 or 1:2) | 55:10 | 52:1 | 3:9 | <.0001 | |
| Intra‐ or postoperative factor | Open conversion (yes:no) | 7:58 | 0:53 | 7:5 | <.0001 |
| LSC with fenestrating or reconstituting (yes:no) | 4:61 | 0:53 | 5:7 | <.0001 | |
| Subtotal cholecystectomy with fenestrating or reconstituting (yes:no) | 6:59 | 0:53 | 7:5 | <.0001 | |
| BDI during operation (yes:no) | 1:64 | 0:53 | 1:11 | .034 | |
| Grade of Clavien–Dindo classification ≤3 (yes:no) | 5:65 | 4:49 | 1:11 | .236 |
Abbreviations:ASA‐PS, the American Society of Anesthesiologists physical status classification; BDI, bile duct injury; BMI, body mass index; CCI, Age‐adjusted Charlson comorbidity index; CRP, C‐reactive protein; DM, diabetes mellitus; GB, gallbladder; HT, hypertension; LC, laparoscopic cholecystectomy; LSC, laparoscopic subtotal cholecystectomy; NA, not available; PTGBD, percutaneous transhepatic gallbladder drainage; SILS, single‐port laparoscopic surgery; WBC, white blood cell.
Patient characteristics with a score of 2
| Factor 〔Median (minimum to maximum) or Ratio〕 | OC | LC with bailout procedure |
| ||
|---|---|---|---|---|---|
| (n = 9) | (n = 18) | ||||
| LSC | Open conversion | ||||
| (n = 4) | (n = 14) | ||||
| Preoperative factor | Age (years old) | 73 (39–91) | 66.5 (43–90) | 0.705 | |
| Gender (male:female) | 7:2 | 14:4 | 1.000 | ||
| BMI | 21.0 (17.1–41.0) | 23.8 (16.4–30.0) | 0.495 | ||
| SILS (yes:no) | 0:9 | 1:17 | 0.471 | ||
| ASA–PS (1:2:3) | 1:7:1 | 1:16:1 | 0.746 | ||
| CCI ( ≤ 5:6 ≤) | 7:2 | 15:3 | 0.726 | ||
| HT (yes:no) | 4:5 | 12:6 | 0.268 | ||
| DM (yes:no) | 2:7 | 4:14 | 1.000 | ||
| Past history of upper abdominal surgery (yes:no) | 2:7 | 0:18 | 0.038 | ||
| Anticoagulative therapy (yes:no) | 3:6 | 3:15 | 0.326 | ||
| Time until PTGBD after symptom onset (days) | 4 (3–17) | 5 (3–16) | 0.860 | ||
| Time until surgery after PTGBD (days) | 29 (5–232) | 53.5 (5–102) | 0.348 | ||
| Gallbladder wall thickness (mm) | 13 (10–25) | 12 (10–21) | 0.312 | ||
| Maximal diameter of impacted stone (mm) | 8 (0–33) | 6.5 (2–29) | 0.781 | ||
| Maximal WBC count in the peripheral blood (/μL) | 16 500 (12 200–20,400) | 14 700 (8700–39,300) | 0.860 | ||
| Maximal serum value of CRP (mg/dL) | 25.03 (13.30–31.08) | 20.65 (13.25–36.04) | 0.348 | ||
| Intra‐ or postoperative factor | Op time (min) | 131 (82–514) | 164.5 (80–420) | 0.176 | |
| Estimated blood loss during operation (g) | 105 (5–510) | 100 (5‐1,350) | 0.668 | ||
| Open conversion (yes:no) | 0:9 | 14:4 | <0.0001 | ||
| LSC with fenestrating or reconstituting (yes:no) | 0:9 | 4:14 | 0.125 | ||
| Subtotal cholecystectomy with fenestrating or reconstituting (yes:no) | 3:6 | 10:8 | 0.276 | ||
| BDI during operation between two groups (yes:no) | 0:9 | 4:14 | 0.125 | ||
| BDI during operation among three groups (yes:no) | 0:9 | 0:4 | 4:10 | 0.113 | |
| Grade of Clavien–Dindo classification ≤3 between two groups (yes:no) | 0:9 | 2:16 | 0.299 | ||
| Grade of Clavien–Dindo classification ≤3 among three groups (yes:no) | 0:9 | 0:4 | 2:12 | 0.367 | |
Abbreviations: ASA‐PS, the American Society of Anesthesiologists physical status classification; BDI, bile duct injury; BMI, body mass index; CCI, Age‐adjusted Charlson comorbidity index; CRP, C‐reactive protein; DM, diabetes mellitus; GB, gallbladder; HT, hypertension; LC, laparoscopic cholecystectomy; LSC, laparoscopic subtotal cholecystectomy; NA, not available; OC, open cholecystectomy from the beginning; PTGBD, percutaneous transhepatic gallbladder drainage; SILS, single‐port laparoscopic surgery; WBC, white blood cell.